295 related articles for article (PubMed ID: 24782261)
21. Evolution of the Humoral Response during HCV Infection: Theories on the Origin of Broadly Neutralizing Antibodies and Implications for Vaccine Design.
Murira A; Lapierre P; Lamarre A
Adv Immunol; 2016; 129():55-107. PubMed ID: 26791858
[TBL] [Abstract][Full Text] [Related]
22. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery.
Christiansen D; Earnest-Silveira L; Grubor-Bauk B; Wijesundara DK; Boo I; Ramsland PA; Vincan E; Drummer HE; Gowans EJ; Torresi J
Sci Rep; 2019 Jun; 9(1):9251. PubMed ID: 31239471
[TBL] [Abstract][Full Text] [Related]
23. [Development approaches for vaccines against hepatitis C virus infections].
Bankwitz D; Krey T; Pietschmann T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):183-191. PubMed ID: 35015104
[TBL] [Abstract][Full Text] [Related]
24. HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.
Amador-Cañizares Y; Martínez-Donato G; Alvarez-Lajonchere L; Vasallo C; Dausá M; Aguilar-Noriega D; Valenzuela C; Raíces I; Dubuisson J; Wychowski C; Cinza-Estévez Z; Castellanos M; Núñez M; Armas A; González Y; Revé I; Guerra I; Pérez Aguiar A; Dueñas-Carrera S
World J Gastroenterol; 2014 Jan; 20(1):148-62. PubMed ID: 24415868
[TBL] [Abstract][Full Text] [Related]
25. A new insight into hepatitis C vaccine development.
Yu CI; Chiang BL
J Biomed Biotechnol; 2010; 2010():548280. PubMed ID: 20625493
[TBL] [Abstract][Full Text] [Related]
26. Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance.
Merat SJ; Bru C; van de Berg D; Molenkamp R; Tarr AW; Koekkoek S; Kootstra NA; Prins M; Ball JK; Bakker AQ; de Jong MD; Spits H; Beaumont T; Schinkel J
J Hepatol; 2019 Jul; 71(1):14-24. PubMed ID: 30797052
[TBL] [Abstract][Full Text] [Related]
27. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
[TBL] [Abstract][Full Text] [Related]
28. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
Page K; Melia MT; Veenhuis RT; Winter M; Rousseau KE; Massaccesi G; Osburn WO; Forman M; Thomas E; Thornton K; Wagner K; Vassilev V; Lin L; Lum PJ; Giudice LC; Stein E; Asher A; Chang S; Gorman R; Ghany MG; Liang TJ; Wierzbicki MR; Scarselli E; Nicosia A; Folgori A; Capone S; Cox AL
N Engl J Med; 2021 Feb; 384(6):541-549. PubMed ID: 33567193
[TBL] [Abstract][Full Text] [Related]
29. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
[TBL] [Abstract][Full Text] [Related]
30. Containing "The Great Houdini" of viruses: combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C.
Ahlén G; Frelin L; Brenndörfer ED; Brass A; Weiland O; Chen M; Sällberg M
Drug Resist Updat; 2013; 16(3-5):60-7. PubMed ID: 23911647
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder.
Yost SA; Wang Y; Marcotrigiano J
Front Immunol; 2018; 9():1917. PubMed ID: 30197646
[TBL] [Abstract][Full Text] [Related]
32. Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.
Phelps CC; Walker CM; Honegger JR
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372558
[TBL] [Abstract][Full Text] [Related]
33. Advances in DNA immunization against hepatitis C virus infection.
Alvarez-Lajonchere L; Dueñas-Carrera S
Hum Vaccin; 2009 Aug; 5(8):568-71. PubMed ID: 19736511
[TBL] [Abstract][Full Text] [Related]
34. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
Torresi J; Johnson D; Wedemeyer H
J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
[TBL] [Abstract][Full Text] [Related]
35. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
36. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
37. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.
Lee H; Jeong M; Oh J; Cho Y; Shen X; Stone J; Yan J; Rothkopf Z; Khan AS; Cho BM; Park YK; Weiner DB; Son WC; Maslow JN
Sci Rep; 2017 Mar; 7():43531. PubMed ID: 28266565
[TBL] [Abstract][Full Text] [Related]
38. Canola oilseed- and Escherichia coli- derived hepatitis C virus (HCV) core proteins adjuvanted with oil bodies, induced robust Th1-oriented immune responses in immunized mice.
Mohammadzadeh S; Roohvand F; Ehsani P; Salmanian AH; Ajdary S
APMIS; 2020 Nov; 128(11):593-602. PubMed ID: 32870528
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.
Fauvelle C; Colpitts CC; Keck ZY; Pierce BG; Foung SK; Baumert TF
Expert Rev Vaccines; 2016 Dec; 15(12):1535-1544. PubMed ID: 27267297
[TBL] [Abstract][Full Text] [Related]
40. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
Baumert TF; Fauvelle C; Chen DY; Lauer GM
J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
